2-(Aminomethyl)-benzamide-based glycine transporter type-2 inhibitors

Author： Ho K.-K. Appell K.C. Baldwin J.J. Bohnstedt A.C. Dong G. Guo T. Horlick R. Islam K.R. Kultgen S.G. Masterson C.M. McDonald E. McMillan K. Morphy J.R. Rankovic Z. Sundaram H. Webb M.

Publisher： Elsevier

ISSN： 0960-894X

Source： Bioorganic and Medicinal Chemistry Letters, Vol.14, Iss.2, 2004-01, pp. : 545-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibitors of islet amyloid polypeptide fibrillogenesis, and the treatment of type-2 diabetes

By Louise A. Scrocchi

Letters in Peptide Science, Vol. 10, Iss. 5, 2003-01 ,pp. : 545-551

Springer Publishing Company

Access to resources Recommend Favorite

Incretin-Based Therapy of Type 2 Diabetes Mellitus

Current Protein and Peptide Science, Vol. 10, Iss. 1, 2009-02 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR study of substituted 2-pyridinyl guanidines as selective urokinase-type plasminogen activator (uPA) inhibitors

By Karthikeyan C. Moorthy N.S. Hari Narayana Trivedi Piyush

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 24, Iss. 1, 2009-02 ,pp. : 6-13

Informa Healthcare

Access to resources Recommend Favorite

N-substituted 4-(4-carboxyphenoxy)benzamides. Synthesis and Evaluation as Inhibitors of Steroid-5α-reductase Type 1 and 2

By Picard Franck Hartmann Rolf W.

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 17, Iss. 3, 2002-01 ,pp. : 187-196

Informa Healthcare

Access to resources Recommend Favorite

Molecular dynamics (MD) simulations and binding free energy calculation studies between inhibitors and type II dehydroquinase (DHQ2)

By Chu Wen-Ting Zheng Qing-Chuan Wu Yun-Jian Zhang Ji-Long Liang Chong-Yang Chen Lin Xue Qiao Zhang Hong-Xing

Molecular Simulation, Vol. 39, Iss. 2, 2013-02 ,pp. : 137-144

Taylor & Francis Ltd

Access to resources Recommend Favorite